FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011949> ?p ?o ?g. }

• W4377011949 abstract "Abstract Background Renal fibrosis is the late stage of many chronic kidney diseases (CKD). Clinically, there is almost no effective treatment for renal fibrosis except dialysis. Renshen Guben oral liquid (RSGB) is a Chinese patent medicine approved by National Medical Products Administration (NMPA), which is suitable for clinical patients with chronic nephritis. Currently, the chemical constituents of RSGB remains unclear, and its efficacy and mechanism on renal fibrosis have not been reported. Methods In our research, ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS/MS) was employed to describe the chemical profile of RSGB, unilateral ureteral obstruction (UUO) model in mice was established to evaluate the beneficial effect of RSGB on renal fibrosis by biochemical indexes, HE and Masson staining. RNA sequencing and “constituents-targets-pathways” multi-dimensional network was established to mine the mechanisms of RSGB. Key targets were verified by quantitative real-time PCR (qRT-PCR) and western bolt (WB). Results A total of 201 constituents were identified or tentatively characterized, 15 of which were confirmed with standards. The number of triterpenes was the highest with 49, followed by phenols with 46. RSGB ameliorated the blood urea nitrogen (BUN) and serum creatinine (Scr) levels in serum, normalizing pathological structure of kidney tissue. RNA sequencing revealed that RSGB regulates 226 differential genes, which were involved in kidney development. According to the “constituents-targets-pathways” network, 26 key active constituents may mainly regulate the inflammatory immune system through 88 corresponding targets. qRT-PCR and WB results showed that RSGB inhibited the activation of the Tgfβ1/Smad2/3 pathway, Wnt4/β-Catenin pathway and NGFR/NF-κB pathway. Conclusions Overall, our study, for the first time, characterized 201 chemical constituents in RSGB, and 26 of them were screened out to alleviates renal fibrosis mainly through Tgfβ1/Smad2/3 pathway, Wnt4/β-catenin pathway and NGFR/NF-κB pathway, which may provide a new research strategy for research on the mechanism of traditional Chinese Medicine." @default.
• W4377011949 created "2023-05-19" @default.
• W4377011949 creator A5008509353 @default.
• W4377011949 creator A5013736647 @default.
• W4377011949 creator A5014214726 @default.
• W4377011949 creator A5032101557 @default.
• W4377011949 creator A5032451475 @default.
• W4377011949 creator A5036919705 @default.
• W4377011949 creator A5051439492 @default.
• W4377011949 creator A5063446960 @default.
• W4377011949 creator A5064530138 @default.
• W4377011949 creator A5076165068 @default.
• W4377011949 date "2023-05-17" @default.
• W4377011949 modified "2023-10-16" @default.
• W4377011949 title "Identification of the Main Chemical constituents and mechanism of Renshen Guben oral liquid against Renal Fibrosis" @default.
• W4377011949 cites W2013144394 @default.
• W4377011949 cites W2031075112 @default.
• W4377011949 cites W2135919238 @default.
• W4377011949 cites W2170248012 @default.
• W4377011949 cites W2342679639 @default.
• W4377011949 cites W2347076418 @default.
• W4377011949 cites W2579074098 @default.
• W4377011949 cites W2621172390 @default.
• W4377011949 cites W2768412315 @default.
• W4377011949 cites W2771608045 @default.
• W4377011949 cites W2778815600 @default.
• W4377011949 cites W2804946677 @default.
• W4377011949 cites W2899712363 @default.
• W4377011949 cites W2914120784 @default.
• W4377011949 cites W2974204766 @default.
• W4377011949 cites W2975310690 @default.
• W4377011949 cites W2979236832 @default.
• W4377011949 cites W2992524785 @default.
• W4377011949 cites W3014111190 @default.
• W4377011949 cites W3036634463 @default.
• W4377011949 cites W3084210108 @default.
• W4377011949 cites W3101089408 @default.
• W4377011949 cites W3108096607 @default.
• W4377011949 cites W3114307722 @default.
• W4377011949 cites W3121341380 @default.
• W4377011949 cites W3127522319 @default.
• W4377011949 cites W3128530944 @default.
• W4377011949 cites W3171210517 @default.
• W4377011949 cites W3182639481 @default.
• W4377011949 cites W3199424845 @default.
• W4377011949 cites W3199602330 @default.
• W4377011949 cites W3216658972 @default.
• W4377011949 cites W4213333499 @default.
• W4377011949 cites W4220665995 @default.
• W4377011949 cites W4223485371 @default.
• W4377011949 cites W4223545618 @default.
• W4377011949 cites W4307371810 @default.
• W4377011949 cites W4308721636 @default.
• W4377011949 cites W4319321476 @default.
• W4377011949 doi "https://doi.org/10.1186/s13020-023-00762-4" @default.
• W4377011949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37198665" @default.
• W4377011949 hasPublicationYear "2023" @default.
• W4377011949 type Work @default.
• W4377011949 citedByCount "0" @default.
• W4377011949 crossrefType "journal-article" @default.
• W4377011949 hasAuthorship W4377011949A5008509353 @default.
• W4377011949 hasAuthorship W4377011949A5013736647 @default.
• W4377011949 hasAuthorship W4377011949A5014214726 @default.
• W4377011949 hasAuthorship W4377011949A5032101557 @default.
• W4377011949 hasAuthorship W4377011949A5032451475 @default.
• W4377011949 hasAuthorship W4377011949A5036919705 @default.
• W4377011949 hasAuthorship W4377011949A5051439492 @default.
• W4377011949 hasAuthorship W4377011949A5063446960 @default.
• W4377011949 hasAuthorship W4377011949A5064530138 @default.
• W4377011949 hasAuthorship W4377011949A5076165068 @default.
• W4377011949 hasBestOaLocation W43770119491 @default.
• W4377011949 hasConcept C126322002 @default.
• W4377011949 hasConcept C142724271 @default.
• W4377011949 hasConcept C188947578 @default.
• W4377011949 hasConcept C204787440 @default.
• W4377011949 hasConcept C2777397596 @default.
• W4377011949 hasConcept C2778176769 @default.
• W4377011949 hasConcept C2780091579 @default.
• W4377011949 hasConcept C2780306776 @default.
• W4377011949 hasConcept C2780559512 @default.
• W4377011949 hasConcept C71924100 @default.
• W4377011949 hasConcept C98274493 @default.
• W4377011949 hasConceptScore W4377011949C126322002 @default.
• W4377011949 hasConceptScore W4377011949C142724271 @default.
• W4377011949 hasConceptScore W4377011949C188947578 @default.
• W4377011949 hasConceptScore W4377011949C204787440 @default.
• W4377011949 hasConceptScore W4377011949C2777397596 @default.
• W4377011949 hasConceptScore W4377011949C2778176769 @default.
• W4377011949 hasConceptScore W4377011949C2780091579 @default.
• W4377011949 hasConceptScore W4377011949C2780306776 @default.
• W4377011949 hasConceptScore W4377011949C2780559512 @default.
• W4377011949 hasConceptScore W4377011949C71924100 @default.
• W4377011949 hasConceptScore W4377011949C98274493 @default.
• W4377011949 hasFunder F4320321001 @default.
• W4377011949 hasIssue "1" @default.
• W4377011949 hasLocation W43770119491 @default.
• W4377011949 hasLocation W43770119492 @default.
• W4377011949 hasLocation W43770119493 @default.
• W4377011949 hasOpenAccess W4377011949 @default.
• W4377011949 hasPrimaryLocation W43770119491 @default.

• next